Biohit Oyj B Stock Fundamentals
| BIOBV Stock | EUR 2.26 0.03 1.35% |
Biohit Oyj B fundamentals help investors to digest information that contributes to Biohit Oyj's financial success or failures. It also enables traders to predict the movement of Biohit Stock. The fundamental analysis module provides a way to measure Biohit Oyj's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biohit Oyj stock.
Biohit |
Biohit Oyj B Company Operating Margin Analysis
Biohit Oyj's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biohit Oyj Operating Margin | 0.1 % |
Most of Biohit Oyj's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biohit Oyj B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biohit Oyj B has an Operating Margin of 0.096%. This is 100.27% lower than that of the Health Care Equipment & Supplies sector and 100.09% lower than that of the Health Care industry. The operating margin for all Finland stocks is 101.74% lower than that of the firm.
Biohit Oyj B Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biohit Oyj's current stock value. Our valuation model uses many indicators to compare Biohit Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biohit Oyj competition to find correlations between indicators driving Biohit Oyj's intrinsic value. More Info.Biohit Oyj B is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 1.01 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Biohit Oyj by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biohit Oyj's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biohit Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biohit Oyj's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biohit Oyj could also be used in its relative valuation, which is a method of valuing Biohit Oyj by comparing valuation metrics of similar companies.Biohit Oyj is currently under evaluation in operating margin category among its peers.
Biohit Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 20.88 M | |||
| Shares Outstanding | 12.07 M | |||
| Shares Owned By Insiders | 47.13 % | |||
| Price To Earning | 11.00 X | |||
| Price To Book | 3.28 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 9.36 M | |||
| Gross Profit | 5.92 M | |||
| EBITDA | 693 K | |||
| Net Income | (1.5 M) | |||
| Cash And Equivalents | 9.38 M | |||
| Cash Per Share | 0.63 X | |||
| Total Debt | 59 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 7.79 X | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | (444 K) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 3.8 | |||
| Number Of Employees | 44 | |||
| Beta | 1.02 | |||
| Market Capitalization | 30.69 M | |||
| Total Asset | 9.61 M | |||
| Retained Earnings | 6 M | |||
| Working Capital | 8 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 1000 K | |||
| Net Asset | 9.61 M |
About Biohit Oyj Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biohit Oyj B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biohit Oyj using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biohit Oyj B based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company was founded in 1988 and is headquartered in Helsinki, Finland. Biohit Oyj operates under Healthcare Services classification in Finland and is traded on Helsinki Exchange. It employs 49 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.